• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

动脉粥样硬化性灌注不足脑微血管中的线粒体DNA缺失作为阿尔茨海默病发展的主要靶点。

Mitochondria DNA deletions in atherosclerotic hypoperfused brain microvessels as a primary target for the development of Alzheimer's disease.

作者信息

Aliyev Ali, Chen Shu G, Seyidova Dilara, Smith Mark A, Perry George, de la Torre Jack, Aliev Gjumrakch

机构信息

The Microscopy Research Center, Case Western Reserve University, Cleveland, OH 44106, USA.

出版信息

J Neurol Sci. 2005 Mar 15;229-230:285-92. doi: 10.1016/j.jns.2004.11.040. Epub 2004 Dec 23.

DOI:10.1016/j.jns.2004.11.040
PMID:15760652
Abstract

The pathogenesis, which is primarily responsible for Alzheimer's disease (AD) and cerebrovascular accidents (CVA), seems to involve chronic hypoperfusion. The role of hypoperfusion, as a key factor for vascular lesions that causes oxidative stress, appears to be widely accepted as an initiator of AD. Specifically, accumulated oxidative stress increases vascular endothelial permeability and promotes leukocyte adhesions, which is coupled with alterations in endothelial signal transduction and redox-regulated transcription factors. Based on these recent findings, we hypothesize that the cellular and molecular mechanisms by which hypoperfusion-induced reactive oxygen species (ROS) accumulation impairs endothelial barrier function and promotes leukocyte adhesion induces alterations in normal vascular function and results in the development of AD. We are theorizing that mitochondria play a key role in the generation of ROS, resulting in oxidative damage to neuronal cell bodies, as well as other cellular compartment in the AD brain. All of these changes have been found to accompany AD pathology. We have studied the ultrastructural features of vascular lesions and mitochondria in brain vascular wall cells from human AD, yeast artificial chromosome (YAC) and C57B6/SJL transgenic positive (Tg+) mice overexpressing amyloid beta precursor protein (AbetaPP). In situ hybridization using mitochondrial DNA (mtDNA) probes for human wild and 5 kb deleted types and mouse types was performed along with immunocytochemistry using antibodies against amyloid precursor protein (APP), 8-hydroxy-2'-guanosine (8-OHG) and cytochrome c oxidase (COX). There was a higher degree of amyloid deposition, overexpression of oxidative stress markers, mitochondria DNA deletion and mitochondrial structural abnormality in the vascular walls of the human AD, YAC and C57B6/SJL Tg (+) mice compared to age-matched controls. Therefore, selective pharmacological intervention, directed for abolishing the chronic hypoperfusion state, would possibly change the natural course of development of dementing neurodegeneration.

摘要

主要导致阿尔茨海默病(AD)和脑血管意外(CVA)的发病机制似乎涉及慢性灌注不足。灌注不足作为导致氧化应激的血管病变的关键因素,其作用似乎已被广泛认为是AD的引发因素。具体而言,累积的氧化应激会增加血管内皮通透性并促进白细胞黏附,这与内皮信号转导和氧化还原调节转录因子的改变相关。基于这些最新发现,我们推测灌注不足诱导的活性氧(ROS)积累损害内皮屏障功能并促进白细胞黏附的细胞和分子机制会导致正常血管功能改变并引发AD的发展。我们推测线粒体在ROS的产生中起关键作用,导致对神经元细胞体以及AD大脑中的其他细胞区室的氧化损伤。所有这些变化都已被发现与AD病理学相伴。我们研究了来自人类AD、酵母人工染色体(YAC)和过表达淀粉样β前体蛋白(AβPP)的C57B6/SJL转基因阳性(Tg+)小鼠的脑血管壁细胞中血管病变和线粒体的超微结构特征。使用针对人类野生型和5 kb缺失型以及小鼠型的线粒体DNA(mtDNA)探针进行原位杂交,并使用针对淀粉样前体蛋白(APP)、8-羟基-2'-鸟苷(8-OHG)和细胞色素c氧化酶(COX)的抗体进行免疫细胞化学。与年龄匹配的对照相比,人类AD、YAC和C57B6/SJL Tg(+)小鼠的血管壁中淀粉样沉积程度更高、氧化应激标志物过表达、线粒体DNA缺失和线粒体结构异常。因此,旨在消除慢性灌注不足状态的选择性药物干预可能会改变痴呆性神经退行性变的自然发展进程。

相似文献

1
Mitochondria DNA deletions in atherosclerotic hypoperfused brain microvessels as a primary target for the development of Alzheimer's disease.动脉粥样硬化性灌注不足脑微血管中的线粒体DNA缺失作为阿尔茨海默病发展的主要靶点。
J Neurol Sci. 2005 Mar 15;229-230:285-92. doi: 10.1016/j.jns.2004.11.040. Epub 2004 Dec 23.
2
Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice.线粒体与血管病变作为转基因小鼠中阿尔茨海默病及阿尔茨海默病样病理发展的核心靶点。
Neurol Res. 2003 Sep;25(6):665-74. doi: 10.1179/016164103101201977.
3
Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels as a central target for the development of human AD and AD-like pathology in aged transgenic mice.动脉粥样硬化病变与脑微血管中的线粒体DNA缺失作为人类阿尔茨海默病(AD)及老年转基因小鼠中AD样病理发展的核心靶点。
Ann N Y Acad Sci. 2002 Nov;977:45-64. doi: 10.1111/j.1749-6632.2002.tb04798.x.
4
Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels: implication in the pathogenesis of Alzheimer's disease.脑微血管中的动脉粥样硬化病变与线粒体DNA缺失:对阿尔茨海默病发病机制的影响。
Vasc Health Risk Manag. 2008;4(3):721-30. doi: 10.2147/vhrm.s2608.
5
Brain mitochondria as a primary target in the development of treatment strategies for Alzheimer disease.脑线粒体作为阿尔茨海默病治疗策略开发的主要靶点。
Int J Biochem Cell Biol. 2009 Oct;41(10):1989-2004. doi: 10.1016/j.biocel.2009.03.015. Epub 2009 Apr 5.
6
Mitochondria as a primary target for vascular hypoperfusion and oxidative stress in Alzheimer's disease.线粒体作为阿尔茨海默病中血管灌注不足和氧化应激的主要靶点。
Mitochondrion. 2004 Sep;4(5-6):649-63. doi: 10.1016/j.mito.2004.07.018.
7
Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease.淀粉样前体蛋白介导的自由基与氧化损伤:对阿尔茨海默病发生发展的影响
J Neurochem. 2006 Jan;96(1):1-13. doi: 10.1111/j.1471-4159.2005.03530.x. Epub 2005 Nov 23.
8
Regional brain metabolism with cytochrome c oxidase histochemistry in a PS1/A246E mouse model of autosomal dominant Alzheimer's disease: correlations with behavior and oxidative stress.载脂蛋白 E 基因 PS1/A246E 突变型阿尔茨海默病小鼠脑区域性细胞色素 c 氧化酶组织化学及与行为学和氧化应激的相关性。
Neurochem Int. 2009 Dec;55(8):806-14. doi: 10.1016/j.neuint.2009.08.005. Epub 2009 Aug 12.
9
Oxidative stress and cerebrovascular dysfunction in mouse models of Alzheimer's disease.阿尔茨海默病小鼠模型中的氧化应激与脑血管功能障碍
Exp Physiol. 2008 Jan;93(1):116-20. doi: 10.1113/expphysiol.2007.038729. Epub 2007 Oct 2.
10
Mitochondrial dysfunction and Alzheimer's disease.线粒体功能障碍与阿尔茨海默病。
Prog Neuropsychopharmacol Biol Psychiatry. 2011 Mar 30;35(2):320-30. doi: 10.1016/j.pnpbp.2010.07.004. Epub 2010 Jul 16.

引用本文的文献

1
Targeted activation of ErbB4 receptor ameliorates neuronal deficits and neuroinflammation in a food-borne polystyrene microplastic exposed mouse model.在食源聚苯乙烯微塑料暴露小鼠模型中,ErbB4受体的靶向激活可改善神经元缺陷和神经炎症。
J Neuroinflammation. 2025 Mar 15;22(1):86. doi: 10.1186/s12974-025-03406-6.
2
From Fundamentals to Innovation in Alzheimer's Disease: Molecular Findings and Revolutionary Therapies.从阿尔茨海默病的基础到创新:分子发现和革命性疗法。
Int J Mol Sci. 2024 Nov 16;25(22):12311. doi: 10.3390/ijms252212311.
3
Alzheimer's Disease-Related Epigenetic Changes: Novel Therapeutic Targets.
阿尔茨海默病相关的表观遗传改变:新的治疗靶点。
Mol Neurobiol. 2024 Mar;61(3):1282-1317. doi: 10.1007/s12035-023-03626-y. Epub 2023 Sep 12.
4
Alzheimer's Disease Puzzle: Delving into Pathogenesis Hypotheses.阿尔茨海默病之谜:深入探究发病机制假说。
Aging Dis. 2024 Feb 1;15(1):43-73. doi: 10.14336/AD.2023.0608.
5
Comprehensive summary of mitochondrial DNA alterations in the postmortem human brain: A systematic review.对死后人脑中线粒体 DNA 改变的综合总结:系统评价。
EBioMedicine. 2022 Feb;76:103815. doi: 10.1016/j.ebiom.2022.103815. Epub 2022 Jan 24.
6
Reactive Oxygen Species (ROS) Regulates Different Types of Cell Death by Acting as a Rheostat.活性氧(ROS)作为变阻器调节不同类型的细胞死亡。
Oxid Med Cell Longev. 2021 Aug 14;2021:9912436. doi: 10.1155/2021/9912436. eCollection 2021.
7
Health Science Community Will Miss This Bright and Uniting Star: In Memory of Professor Gjumrakch Aliev, M.D, Ph.D.健康科学界将怀念这位杰出且凝聚人心的明星:纪念医学博士、哲学博士古姆拉克奇·阿利耶夫教授
Cancers (Basel). 2021 Apr 19;13(8):1965. doi: 10.3390/cancers13081965.
8
Impact of Tau on Neurovascular Pathology in Alzheimer's Disease.Tau蛋白对阿尔茨海默病神经血管病理的影响
Front Neurol. 2021 Jan 7;11:573324. doi: 10.3389/fneur.2020.573324. eCollection 2020.
9
Stem Cells as Potential Targets of Polyphenols in Multiple Sclerosis and Alzheimer's Disease.干细胞作为多酚在多发性硬化症和阿尔茨海默病中潜在的作用靶点。
Biomed Res Int. 2018 Jul 12;2018:1483791. doi: 10.1155/2018/1483791. eCollection 2018.
10
The 20-Year Voyage Aboard the Journal of Alzheimer's Disease: Docking at 'Type 3 Diabetes', Environmental/Exposure Factors, Pathogenic Mechanisms, and Potential Treatments.《阿尔茨海默病杂志》20 年航海之旅:停靠“3 型糖尿病”、环境/暴露因素、发病机制和潜在治疗靶点。
J Alzheimers Dis. 2018;62(3):1381-1390. doi: 10.3233/JAD-170829.